| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5572204 | Clinical Nutrition | 2017 | 47 Pages |
Abstract
Some prebiotics and synbiotics may have immunomodulatory action, however, more randomized controlled trials are needed to support the clinical use of inulin-type fructans, galacto-oligosaccharides or related synbiotics for the treatment of metabolic endotoxaemia or low-grade inflammation in overweight/obese people.
Keywords
FOSTNFRCTIFN-γIL-10PRISMAhs-CRPGOSSCFACFUIL-6Randomized controlled trialPreferred Reporting Items for Systematic reviews and Meta-analysisConsolidated Standards of Reporting TrialsShort-chain fatty acidsOverweightinterferon-gammaInterleukin-10interleukin-6Synbioticsbody mass indexBMItumor necrosis factorfructo-oligosaccharideObesitySystematic reviewcolony forming unitshigh sensitivity C-reactive proteinC-reactive proteinCRPPrebioticsCONSORTgalacto-oligosaccharide
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Ricardo Fernandes, Vinicius A. do Rosario, Michel C. Mocellin, Marilyn G.F. Kuntz, Erasmo B.S.M. Trindade,